Protective potential of experimental autoimmune myasthenia gravis in Lewis rats by IL-10-modified dendritic cells

Banchereau, 1998, Dendritic cells and the control of immunity, Nature, 392, 245, 10.1038/32588 Berman, 1980, Experimental myasthenia gravis. A murine system, J. Exp. Med., 151, 204, 10.1084/jem.151.1.204 Buelens, 1995, Interleukin-10 differentially regulates B7-1 (CD80) and B7-2 (CD86) expression on human peripheral blood dendritic cells, Eur. J. Immunol., 25, 2668, 10.1002/eji.1830250940 Cavani, 2000, Human CD4+ T lymphocytes with remarkable regulatory functions on dendritic cells and nickel-specific Th1 immune responses, J. Invest. Dermatol., 114, 295, 10.1046/j.1523-1747.2000.00881.x Chang, 1995, B7-1 expression of Langerhans cells is up-regulated by proinflammatory cytokines, and is down-regulated by interferon-gamma or by interleukin-10, Eur. J. Immunol., 25, 394, 10.1002/eji.1830250213 Corinti, 2001, Regulatory activity of autocrine IL-10 on dendritic cell functions, J. Immunol., 166, 4312, 10.4049/jimmunol.166.7.4312 D'Amico, 2000, Uncoupling of inflammatory chemokine receptors by IL-10: generation of functional decoys, Nat. Immunol., 1, 387, 10.1038/80819 Demangel, 2002, Autocrine IL-10 impairs dendritic cell (DC)-derived immune responses to mycobacterial infection by suppressing DC trafficking to draining lymph nodes and local IL-12 production, Eur. J. Immunol., 32, 994, 10.1002/1521-4141(200204)32:4<994::AID-IMMU994>3.0.CO;2-6 Dhodapkar, 2001, Antigen-specific inhibition of effector T cell function in humans after injection of immature dendritic cells, J. Exp. Med., 193, 233, 10.1084/jem.193.2.233 Dieu, 1998, Selective recruitment of immature and mature dendritic cells by distinct chemokines expressed in different anatomic sites, J. Exp. Med., 188, 373, 10.1084/jem.188.2.373 Enk, 1993, Inhibition of Langerhans cell antigen-presenting function by IL-10. A role for IL-10 in induction of tolerance, J. Immunol., 151, 2390, 10.4049/jimmunol.151.5.2390 Fazekas de St. Groth, 2001, DCs and peripheral T cell tolerance, Semin. Immunol., 13, 311, 10.1006/smim.2001.0327 Hackstein, 2001, Designer dendritic cells for tolerance induction: guided not misguided missiles, Trends Immunol., 22, 437, 10.1016/S1471-4906(01)01959-7 Howard, 1992, Biological properties of interleukin 10, Immunol. Today, 13, 198, 10.1016/0167-5699(92)90153-X Huang, 1999, Increased levels of circulating acetylcholine receptor (AChR)-reactive IL-10-secreting cells are characteristic for myasthenia gravis (MG), Clin. Exp. Immunol., 118, 304, 10.1046/j.1365-2249.1999.01062.x Jonuleit, 2000, Induction of interleukin 10-producing, nonproliferating CD4(+) T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells, J. Exp. Med., 192, 1213, 10.1084/jem.192.9.1213 Jonuleit, 2001, Dendritic cells as a tool to induce anergic and regulatory T cells, Trends Immunol., 22, 394, 10.1016/S1471-4906(01)01952-4 Keller, 1990, Binding of monomeric immunoglobulins by bone marrow-derived mononuclear phagocytes; its modulation by interferon-gamma, Eur. J. Immunol., 20, 2137, 10.1002/eji.1830200937 Krueger, 2003, Autoantigen-specific protection of non-obese diabetic mice from cyclophosphamide-accelerated diabetes by vaccination with dendritic cells, Diabetologia, 46, 1357, 10.1007/s00125-003-1199-0 Labeur, 1999, Generation of tumor immunity by bone marrow-derived dendritic cells correlates with dendritic cell maturation stage, J. Immunol., 162, 168, 10.4049/jimmunol.162.1.168 Lindstrom, 1981, Production and assay of antibodies to acetylcholine receptors, Methods Enzymol., 74, 432, 10.1016/0076-6879(81)74031-X Macdonald, 1988, The measurement of relative antibody affinity by ELISA using thiocyanate elution, J. Immunol. Methods, 106, 191, 10.1016/0022-1759(88)90196-2 Matusevicius, 1996, Tumor necrosis factor-alpha, lymphotoxin, interleukin (IL)-6, IL-10, IL-12 and perforin mRNA expression in mononuclear cells in response to acetylcholine receptor is augmented in myasthenia gravis, J. Neuroimmunol., 71, 191, 10.1016/S0165-5728(96)00152-X Paas-Rozner, 2001, The nature of the active suppression of responses associated with experimental autoimmune myasthenia gravis by a dual altered peptide ligand administered by different routes, Proc. Natl. Acad. Sci. U. S. A., 98, 12642, 10.1073/pnas.221456798 Poussin, 2000, Suppression of experimental autoimmune myasthenia gravis in IL-10 gene-disrupted mice is associated with reduced B cells and serum cytotoxicity on mouse cell line expressing AChR, J. Neuroimmunol., 111, 152, 10.1016/S0165-5728(00)00385-4 Rizzo, 1992, Generation of B cell memory and affinity maturation. Induction with Th1 and Th2 T cell clones, J. Immunol., 148, 3733, 10.4049/jimmunol.148.12.3733 Sallusto, 1999, Mobilizing dendritic cells for tolerance, priming, and chronic inflammation, J. Exp. Med., 189, 611, 10.1084/jem.189.4.611 Sidman, 1984, Gamma-interferon is one of several direct B cell-maturing lymphokines, Nature, 309, 801, 10.1038/309801a0 Sozzani, 1999, The role of chemokines in the regulation of dendritic cell trafficking, J. Leukocyte Biol., 66, 1, 10.1002/jlb.66.1.1 Steinbrink, 1997, Induction of tolerance by IL-10-treated dendritic cells, J. Immunol., 159, 4772, 10.4049/jimmunol.159.10.4772 Steinbrink, 1999, Interleukin-10-treated human dendritic cells induce a melanoma-antigen-specific anergy in CD8(+) T cells resulting in a failure to lyse tumor cells, Blood, 93, 1634, 10.1182/blood.V93.5.1634 Steinman, 1991, The dendritic cell system and its role in immunogenicity, Annu. Rev. Immunol., 9, 271, 10.1146/annurev.iy.09.040191.001415 Suss, 1996, A subclass of dendritic cells kills CD4 T cells via Fas/Fas-ligand-induced apoptosis, J. Exp. Med., 183, 1789, 10.1084/jem.183.4.1789 Vremec, 1992, The surface phenotype of dendritic cells purified from mouse thymus and spleen: investigation of the CD8 expression by a subpopulation of dendritic cells, J. Exp. Med., 176, 47, 10.1084/jem.176.1.47 Wang, 1999, Enhanced epidermal Langerhans cell migration in IL-10 knockout mice, J. Immunol., 162, 277, 10.4049/jimmunol.162.1.277 Wang, 2000, Tumor necrosis factor receptor-1 is critically involved in the development of experimental autoimmune myasthenia gravis, Int. Immunol., 12, 1381, 10.1093/intimm/12.10.1381 Wang, 2000, Role for interferon-gamma in rat strains with different susceptibility to experimental autoimmune myasthenia gravis, Clin. Immunol., 95, 156, 10.1006/clim.2000.4850 Williamson, 1999, Modulating dendritic cells to optimize mucosal immunization protocols, J. Immunol., 163, 3668, 10.4049/jimmunol.163.7.3668 Wykes, 1998, Dendritic cells interact directly with naive B lymphocytes to transfer antigen and initiate class switching in a primary T-dependent response, J. Immunol., 161, 1313, 10.4049/jimmunol.161.3.1313 Zhang, 1997, Cytokines and the pathogenesis of myasthenia gravis, Muscle Nerve, 20, 543, 10.1002/(SICI)1097-4598(199705)20:5<543::AID-MUS2>3.0.CO;2-9 Zhang, 1999, Mice with IFN-gamma receptor deficiency are less susceptible to experimental autoimmune myasthenia gravis, J. Immunol., 162, 3775, 10.4049/jimmunol.162.7.3775 Zhang, 2001, Interleukin 10 aggravates experimental autoimmune myasthenia gravis through inducing Th2 and B cell responses to AChR, J. Neuroimmunol., 113, 10, 10.1016/S0165-5728(00)00411-2